Clin2
NCT07860021Possibly a fitRecruiting

Vyvgart for stiff person syndrome

Stiff Person Syndrome

Part of Brain & nervous system, Immune system & allergy clinical trials.

This trial tests whether a drug called Vyvgart (hyaluronidase-fjjo) can help people with stiff person syndrome who still have symptoms like stiffness, painful muscle spasms, and trouble walking despite other treatments. The goal is to see if it improves these symptoms and how well it works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
26 people
Ages
25 years to 80 years
Study type
Interventional

Who can take part

  • You must be between 25 and 80 years old.
  • You must have a diagnosis of typical stiff person syndrome (SPS), which causes stiffness, painful muscle spasms, and problems walking.
  • Your current treatments, like IVIg or rituximab, are not working well enough or have stopped being effective.
  • You must test positive for GAD antibodies or glycine receptor antibodies.
  • You must be able to attend study visits at the clinic.
  • You must not have very mild disease (like a stiffness index less than 1) or be non-ambulatory (unable to walk), or have a type of SPS caused by cancer (paraneoplastic).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06528392Not yet recruiting· Phase 2
Efgartigimod for stiff person syndrome

This trial tests a medicine called efgartigimod for stiff person syndrome, a rare autoimmune condition that causes muscle stiffness and spasms. The medicine may reduce the antibodies that attack the nervous system, which could help ease symptoms and improve daily function.

Tampa, Florida
NCT07552987Not yet recruiting· Phase 3
Study of a medication for stiff person syndrome

This study tests an intravenous (IV) medication called human normal immune globulin 10% to see if it helps reduce stiffness and spasms in adults with Stiff Person Syndrome (SPS). It might improve muscle symptoms and quality of life.

NCT07704840Recruiting· Phase 2
Testing a new pill for post-stroke arm stiffness

This study tests an experimental pill (BMS-986368) that targets two brain chemicals to reduce muscle stiffness after a stroke. It's for people who had a stroke in the last 4 to 18 months and have moderate tightness in their elbow and wrist.

Elkins Park, Pennsylvania
NCT07447934Recruiting
Vibration therapy for leg muscle stiffness

This trial tests if gentle vibrations can reduce muscle stiffness (spasticity) in the lower leg after a neurologic condition like stroke or brain injury. You may join if you've had spasticity for at least 6 months and can stand with or without help.

New York, New York
NCT06718413Recruiting· Phase 2
Study on shoulder pain after stroke

This study tests a treatment for shoulder stiffness and pain caused by muscle tightness after a stroke. It focuses on people who still have some limited shoulder movement and may help improve range of motion and comfort.

Baltimore, Maryland
NCT06229626Recruiting
Intensive home training for hereditary spastic paraparesis SPG4

This trial tests an intensive, video-based exercise program for people with a specific type of hereditary spastic paraparesis (SPG4). It aims to see if adding extra training at home can improve walking and strength.

Paris

Hear when a new Stiff Person Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.